Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

rituximab

  • You have access
    Bendamustine Plus Rituximab for Mantle Cell Lymphoma: A Korean, Multicenter Retrospective Analysis
    JUN HO YI, SEOK JIN KIM, JEONG-OK LEE, GYEONG-WON LEE, JAE-YONG KWAK, HYEON-SEOK EOM, JAE-CHEOL JO, YOON SEOK CHOI, SUNG YONG OH and WON SEOG KIM
    Anticancer Research December 2022, 42 (12) 6083-6089; DOI: https://doi.org/10.21873/anticanres.16120
  • You have access
    The Economic Impact of Biosimilars in Oncology and Hematology: The Case of Trastuzumab and Rituximab
    JACOPO GIULIANI and ANDREA BONETTI
    Anticancer Research July 2019, 39 (7) 3971-3973; DOI: https://doi.org/10.21873/anticanres.13552
  • You have access
    Comparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
    BARTOSZ PUŁA, BOŻENA KATARZYNA BUDZISZEWSKA, JUSTYNA RYBKA, LIDIA GIL, EDYTA SUBOCZ, MONIKA DŁUGOSZ-DANECKA, DARIA ZAWIRSKA, ANNA WASZCZUK-GAJDA, ELŻBIETA ISKIERKA-JAŻDŻEWSKA, AGNIESZKA KOPACZ, AGNIESZKA SZYMCZYK, JAROSŁAW CZYŻ, EWA LECH-MARAŃDA, KRZYSZTOF WARZOCHA and KRZYSZTOF JAMROZIAK
    Anticancer Research May 2018, 38 (5) 3025-3030;
  • You have access
    Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma
    KENNETH P. BYRD, NAMRATHA R. VONTELA, BRENNAN MCCULLAR and MIKE G. MARTIN
    Anticancer Research December 2017, 37 (12) 6839-6843;
  • You have access
    Bendamustin–Rituximab Combination Is a Safe and Effective, Ambulatory Treatment for Elderly Patients with Chronic Lymphocytic Leukemia: Retrospective Real-world Analysis by Age from a German Registry and Review of the Literature
    ULRICH RICHARD KLEEBERG, HARTMUT LINDE, GEORG GÜNTHER, HANS-WERNER TESSEN and MARKUS KERSTING
    Anticancer Research June 2016, 36 (6) 2827-2838;
  • You have access
    Chronic Lymphocytic Leukemia: Current Concepts
    EUN-MI YU, ADAM KITTAI and IMAD A. TABBARA
    Anticancer Research October 2015, 35 (10) 5149-5165;
  • You have access
    Routine Use of Bendamustine in Patients with Chronic Lymphocytic Leukemia: An Observational Study
    MARIJANA NINKOVIC, MICHAEL FIEGL, MICHAEL MIAN, PATRIZIA MONDELLO, FLORIAN KOCHER, CHRISTIAN WALDTHALER, IRMGARD VERDORFER, MICHAEL STEURER, GÜNTHER GASTL and ANDREAS PIRCHER
    Anticancer Research September 2015, 35 (9) 5129-5139;
  • You have access
    Risk of Second Primary Cancer in Patients with B-cell Non-Hodgkin Lymphoma Receiving Rituximab-containing Chemotherapy: A Nationwide Population-based Study
    SHIH-FENG CHO, WAN-HSUAN WU, YI-HSIN YANG and CHAO-SUNG CHANG
    Anticancer Research March 2015, 35 (3) 1809-1814;
  • You have access
    Radiotherapy for Stage I/II Follicular Lymphoma (FL): Is it Time for A Re-appraisal?
    PATRIZIA MONDELLO, NORMANN STEINER, INES WASLE, VINCENZO PITINI and MICHAEL MIAN
    Anticancer Research November 2014, 34 (11) 6701-6704;
  • You have access
    Survival in Advanced Diffuse Large B-Cell Lymphoma in Pre- and Post-rituximab Eras in the United States
    BINAY KUMAR SHAH, AMIR BISTA and BAHMAN SHAFII
    Anticancer Research September 2014, 34 (9) 5117-5120;

Pages

  • Next
  • 1
  • 2
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire